The Microbiome Drives Mast Cell Recruitment in the Skin

微生物组驱动皮肤中肥大细胞的募集

基本信息

  • 批准号:
    8691549
  • 负责人:
  • 金额:
    $ 16.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-18 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Current literature supports the concept that mast cells (MCs) play a relevant role in fighting infections in general, and our recently published data confirms that MCs play an important role in fighting viral pathogens. Despite their importance in innate and acquired immunity, mast cell development and migration into the skin is not well understood. Our findings suggest that the skin microbiome has a strong influence on migrating MCs into the skin. Our preliminary data provide evidence that the presence of bacterial products at the skin surface participates in the regulation of MC antimicrobial functions, driving them to the skin, and synergistically helping them respond to their survival growth factor, SCF. We hypothesize that TLR2 microbiome products have a unique role in MC recruitment at the outside skin interface and define the environment that directs mast cell trafficking and antimicrobial maturation. In Aim 1 we will define the interactions between the skin microbiome and MC innate immune responses in-vivo, with relevance for human pharmacology. In Aim 2 we will analyze molecular mechanisms governing the crosstalk between TLR2 signals released by the skin microbiome and MC innate immune responses, with direct application to human MCs. In Aim 3 we will determine the impact of TLR2 activation on the SCF response and MC maturation with direct correlation of MC antimicrobial functions. At the conclusion of these studies, we will have expanded our knowledge of important new aspects of MC functions and recruitment, evaluated new in-vivo models of interaction between Mast Cells and Commensal bacteria, identified candidate strategies to improve these interactions, and developed new tools for continued investigation into the pathogenesis of MC disorders. More specifically, this work has implications for fighting infections, psoriasis, and atopic dermatitis (eczema), with longer term significance fr asthma and hay fever.
描述(由申请人提供):目前的文献支持肥大细胞(MC)在抵抗感染中发挥相关作用的概念,我们最近发表的数据证实MC在抵抗病毒病原体中发挥重要作用。尽管它们在先天性和获得性免疫中的重要性,但肥大细胞发育和向皮肤中的迁移尚未得到很好的理解。我们的研究结果表明,皮肤微生物组对迁移到皮肤中的MC有很大的影响。我们的初步数据提供了证据,表明皮肤表面细菌产物的存在参与了MC抗菌功能的调节,将它们驱动到皮肤,并协同帮助它们对其生存生长因子SCF做出反应。我们假设TLR2微生物组产物在皮肤外界面的MC募集中具有独特的作用,并定义了指导肥大细胞运输和抗菌剂成熟的环境。在目标1中,我们将定义体内皮肤微生物组和MC先天免疫应答之间的相互作用,与人体药理学相关。在目标2中,我们将分析控制皮肤微生物组释放的TLR2信号与MC先天免疫应答之间串扰的分子机制,并直接应用于人类MC。在目标3中,我们将确定TLR2活化对SCF应答和MC成熟的影响,并与MC抗微生物功能直接相关。在这些研究的结论,我们将扩大我们的MC功能和招聘的重要新方面的知识,评估肥大细胞和共生细菌之间的相互作用的新的体内模型,确定候选策略,以改善这些相互作用,并开发新的工具,继续调查MC疾病的发病机制。更具体地说,这项工作对对抗感染、银屑病和特应性皮炎(湿疹)有意义,对哮喘和花粉热有长期意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna Di Nardo其他文献

Anna Di Nardo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anna Di Nardo', 18)}}的其他基金

Bacterial Mast cell conditioning modulates skin allergic reactions
细菌肥大细胞调理调节皮肤过敏反应
  • 批准号:
    9092598
  • 财政年份:
    2016
  • 资助金额:
    $ 16.21万
  • 项目类别:
The Microbiome Drives Masts Cell Recruitment in the Skin
微生物组驱动皮肤中肥大细胞的募集
  • 批准号:
    8960922
  • 财政年份:
    2014
  • 资助金额:
    $ 16.21万
  • 项目类别:
The Microbiome Drives Masts Cell Recruitment in the Skin
微生物组驱动皮肤中肥大细胞的募集
  • 批准号:
    9044386
  • 财政年份:
    2014
  • 资助金额:
    $ 16.21万
  • 项目类别:
Mast cells in skin innate immune defense
皮肤先天免疫防御中的肥大细胞
  • 批准号:
    10076271
  • 财政年份:
    2011
  • 资助金额:
    $ 16.21万
  • 项目类别:
Mast cells in skin innate immune defense
皮肤先天免疫防御中的肥大细胞
  • 批准号:
    10333319
  • 财政年份:
    2011
  • 资助金额:
    $ 16.21万
  • 项目类别:
Mast cells in skin innate immune defense
皮肤先天免疫防御中的肥大细胞
  • 批准号:
    8248278
  • 财政年份:
    2011
  • 资助金额:
    $ 16.21万
  • 项目类别:
Mast cells in skin innate immune defense
皮肤先天免疫防御中的肥大细胞
  • 批准号:
    8816029
  • 财政年份:
    2011
  • 资助金额:
    $ 16.21万
  • 项目类别:
Mast cells in skin innate immune defense
皮肤先天免疫防御中的肥大细胞
  • 批准号:
    10552573
  • 财政年份:
    2011
  • 资助金额:
    $ 16.21万
  • 项目类别:
Mast cells in skin innate immune defense
皮肤先天免疫防御中的肥大细胞
  • 批准号:
    8441626
  • 财政年份:
    2011
  • 资助金额:
    $ 16.21万
  • 项目类别:
Mast cells in skin innate immune defense
皮肤先天免疫防御中的肥大细胞
  • 批准号:
    8087560
  • 财政年份:
    2011
  • 资助金额:
    $ 16.21万
  • 项目类别:

相似海外基金

Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
  • 批准号:
    2902098
  • 财政年份:
    2024
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Studentship
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
  • 批准号:
    BB/Y004035/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
  • 批准号:
    EP/Z533026/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Research Grant
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
  • 批准号:
    FT230100468
  • 财政年份:
    2024
  • 资助金额:
    $ 16.21万
  • 项目类别:
    ARC Future Fellowships
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
  • 批准号:
    MR/Y033809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
  • 批准号:
    494853
  • 财政年份:
    2023
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
  • 批准号:
    2904356
  • 财政年份:
    2023
  • 资助金额:
    $ 16.21万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了